stock.name

TG Therapeutics Inc

TGTX

Market Cap$2.16B
Close$

Compare TG Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
TG Therapeutics IncTG Therapeutics Inc165.40%8%140.6
marketMarket Avg591.3%30%-1
HealthcareHealthcare Avg64.41.34%15%-0.9
$16.18

Current Fair Value

15.8% upside

Undervalued by 15.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.16 Billion
Enterprise Value$2.04 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.09
Beta1.41
Outstanding Shares154,420,772
Avg 30 Day Volume2,439,297

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio165.39
PEG-224.92
Price to Sales13.98
Price to Book Ratio13.98
Enterprise Value to Revenue8.74
Enterprise Value to EBIT99.01
Enterprise Value to Net Income156
Total Debt to Enterprise0.05
Debt to Equity0.62

Revenue Sources

No data

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss